Efficacy of Aripiprazole in Comorbid Addiction in Bipolar Disorder

CNS Neuroscience and Therapeutics

Volumn 18, Issue 4, 2012, Pages 359-360

  Geoffroy, Pierre Alexis ^a,b   Goddefroy, Guillaume ^a,b   Rolland, Benjamin ^a,b,c   Cottencin, Olivier ^a,b  

^a UNIV LILLE   (France)

^b CHULille ^*  (France)

^c EA   (France)

Author keywords

Addiction; Antipsychotic medication; Bipolar Disorder; Dopamine agonist; Substance use disorder

Indexed keywords

ARIPIPRAZOLE;

ADDICTION; ADULT; ANAMNESIS; ARTICLE; BIPOLAR II DISORDER; CASE REPORT; COMORBIDITY; DRUG EFFICACY; HUMAN; MALE; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; HUMANS; MALE; PIPERAZINES; QUINOLONES; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84859489948     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2012.00301.x     Document Type: Article

References (10)

1. Stinson FS, Grant BF, Dawson DA, Ruan WJ, Huang B, Saha T. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: Results from the National Epidemiologic Survey on alcohol and related conditions. Drug Alcohol Depend 2005;80: 105-116.
2. Singh JB, Zarate CA, Jr. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: A review of controlled trials. Bipolar Disord 2006;8(6): 696-709.
3. Fountoulakis KN, Vieta E, Schmidt F. Aripiprazole monotherapy in the treatment of bipolar disorder: A meta-analysis. J Affect Disord 2011;133: 361-370.
4. Feltenstein MW, Do PH, See RE. Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse. Psychopharmacology (Berl) 2009;207:401-411.
5. Vergne DE, Anton RF. Aripiprazole: A drug with a novel mechanism of action and possible efficacy for alcohol dependence. CNS Neurol Disord Drug Targets 2010;9: 50-54.
6. Association AP. Diagnostic and statistical manual of mental disorders DSM-IV-TR, 4th ed. Arlington, USA: American Psychiatric Publishing, Inc., 2000.
7. Angst J, Adolfsson R, Benazzi F, et al. The HCL-32: Towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord 2005;88:217-233.
8. Schwabe K, Koch M. Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats. Psychopharmacology (Berl) 2007;191:759-765.
9. Pilla M, Perachon S, Sautel F, et al. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 1999;400:371-375.
10. Brown ES, Jeffress J, Liggin JDM, Garza M, Beard L. Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole. J Clin Psychiatry 2005;66:756-760.